ATE218064T1 - Immunogene tlp-zusammensetzung - Google Patents
Immunogene tlp-zusammensetzungInfo
- Publication number
- ATE218064T1 ATE218064T1 AT97945086T AT97945086T ATE218064T1 AT E218064 T1 ATE218064 T1 AT E218064T1 AT 97945086 T AT97945086 T AT 97945086T AT 97945086 T AT97945086 T AT 97945086T AT E218064 T1 ATE218064 T1 AT E218064T1
- Authority
- AT
- Austria
- Prior art keywords
- seq
- immunogenic
- tlp
- composition
- tlp composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000002163 immunogen Effects 0.000 title abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 208000008385 Urogenital Neoplasms Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 230000001173 tumoral effect Effects 0.000 abstract 1
- 208000037964 urogenital cancer Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
- A61K2239/55—Lung
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/80—Vaccine for a specifically defined cancer
- A61K2039/86—Lung
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/80—Vaccine for a specifically defined cancer
- A61K2039/892—Reproductive system [uterus, ovaries, cervix, testes]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT96RM000687A IT1294967B1 (it) | 1996-10-09 | 1996-10-09 | Composizione immunogenica da tlp |
| PCT/IT1997/000240 WO1998015282A1 (en) | 1996-10-09 | 1997-10-09 | Immunogenic tlp composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE218064T1 true ATE218064T1 (de) | 2002-06-15 |
Family
ID=11404462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97945086T ATE218064T1 (de) | 1996-10-09 | 1997-10-09 | Immunogene tlp-zusammensetzung |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20020031531A1 (de) |
| EP (1) | EP0938329B1 (de) |
| JP (1) | JP2001508764A (de) |
| KR (1) | KR20000048995A (de) |
| CN (1) | CN1239431A (de) |
| AT (1) | ATE218064T1 (de) |
| AU (1) | AU725218B2 (de) |
| CA (1) | CA2267905A1 (de) |
| DE (2) | DE938329T1 (de) |
| DK (1) | DK0938329T3 (de) |
| ES (1) | ES2138574T3 (de) |
| IL (1) | IL129368A0 (de) |
| IT (1) | IT1294967B1 (de) |
| NO (1) | NO991653L (de) |
| PT (1) | PT938329E (de) |
| RU (1) | RU2192274C2 (de) |
| WO (1) | WO1998015282A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1317853B1 (it) * | 2000-02-25 | 2003-07-15 | Unihart Corp | Peptidi tlp e sequenze di dna che li codificano. |
| DE10115740A1 (de) | 2001-03-26 | 2002-10-02 | Ulrich Speck | Zubereitung für die Restenoseprophylaxe |
| DE10244847A1 (de) | 2002-09-20 | 2004-04-01 | Ulrich Prof. Dr. Speck | Medizinische Vorrichtung zur Arzneimittelabgabe |
| ES2394969T3 (es) | 2004-12-30 | 2013-02-07 | Vito Michele Fazio | Péptidos inmunógenos antitumorales y vacuna que los contiene |
| EP2252690A2 (de) * | 2007-12-21 | 2010-11-24 | Coda Therapeutics, Inc. | Verwendung von anti-connexin-43-polynukleotiden zur behandlung abnormaler oder übermässiger narben |
| ITRM20100256A1 (it) * | 2010-05-19 | 2011-11-20 | Farmafin Spa | Un nuovo biomarcatore per la diagnosi precoce e l'immunoterapia del cancro |
| EP3167898A1 (de) | 2015-11-11 | 2017-05-17 | IEO - Istituto Europeo di Oncologia Srl | Verfahren zur gewinnung von tumorpeptiden und verwendungen davon |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1206250B (it) * | 1987-02-18 | 1989-04-14 | Ist Farmacoterapico It Spa | Stiche umane e relativi prodotti metodo per l'estrazione di antigeni di membrana aventi proprieta' immunogene a partire da cellule neopla- |
| IT1262954B (it) * | 1992-07-03 | 1996-07-23 | Ist Farmacoterapico It Spa | Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi. |
-
1996
- 1996-10-09 IT IT96RM000687A patent/IT1294967B1/it active IP Right Grant
-
1997
- 1997-10-09 EP EP97945086A patent/EP0938329B1/de not_active Expired - Lifetime
- 1997-10-09 PT PT97945086T patent/PT938329E/pt unknown
- 1997-10-09 KR KR1019990703053A patent/KR20000048995A/ko not_active Application Discontinuation
- 1997-10-09 JP JP51736198A patent/JP2001508764A/ja active Pending
- 1997-10-09 WO PCT/IT1997/000240 patent/WO1998015282A1/en not_active Application Discontinuation
- 1997-10-09 AU AU46376/97A patent/AU725218B2/en not_active Ceased
- 1997-10-09 RU RU98112608/14A patent/RU2192274C2/ru not_active IP Right Cessation
- 1997-10-09 CN CN97180260A patent/CN1239431A/zh active Pending
- 1997-10-09 DK DK97945086T patent/DK0938329T3/da active
- 1997-10-09 US US09/284,051 patent/US20020031531A1/en not_active Abandoned
- 1997-10-09 CA CA002267905A patent/CA2267905A1/en not_active Abandoned
- 1997-10-09 AT AT97945086T patent/ATE218064T1/de not_active IP Right Cessation
- 1997-10-09 IL IL12936897A patent/IL129368A0/xx unknown
- 1997-10-09 DE DE0938329T patent/DE938329T1/de active Pending
- 1997-10-09 DE DE69712907T patent/DE69712907T2/de not_active Expired - Fee Related
- 1997-10-09 ES ES97945086T patent/ES2138574T3/es not_active Expired - Lifetime
-
1999
- 1999-04-08 NO NO991653A patent/NO991653L/no not_active Application Discontinuation
-
2003
- 2003-07-31 US US10/631,838 patent/US20040022870A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2267905A1 (en) | 1998-04-16 |
| AU725218B2 (en) | 2000-10-05 |
| US20020031531A1 (en) | 2002-03-14 |
| DE69712907D1 (de) | 2002-07-04 |
| IL129368A0 (en) | 2000-02-17 |
| EP0938329A1 (de) | 1999-09-01 |
| NO991653D0 (no) | 1999-04-08 |
| IT1294967B1 (it) | 1999-04-23 |
| AU4637697A (en) | 1998-05-05 |
| RU2192274C2 (ru) | 2002-11-10 |
| WO1998015282A1 (en) | 1998-04-16 |
| DK0938329T3 (da) | 2002-09-09 |
| DE69712907T2 (de) | 2002-12-12 |
| EP0938329B1 (de) | 2002-05-29 |
| US20040022870A1 (en) | 2004-02-05 |
| DE938329T1 (de) | 2000-04-06 |
| KR20000048995A (ko) | 2000-07-25 |
| JP2001508764A (ja) | 2001-07-03 |
| ES2138574T3 (es) | 2002-11-01 |
| PT938329E (pt) | 2002-10-31 |
| NO991653L (no) | 1999-06-08 |
| CN1239431A (zh) | 1999-12-22 |
| ES2138574T1 (es) | 2000-01-16 |
| ITRM960687A1 (it) | 1998-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2258383A3 (de) | Von der Telomerase abgeleitete antigene Peptide | |
| HUP9901186A2 (hu) | Peptid-és adjuvánsalapú gyógyszerkészítmény immunmodulációra | |
| HK1043475A1 (en) | Compositions and methods for treating infections using analogues of indolicidin | |
| EP1484339A3 (de) | Kallikreinhemmende "Kunitz-Domäne"Proteine dafür kodierende Nukleinsäure | |
| ATE280826T1 (de) | Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen | |
| NZ516381A (en) | Lung tumor proteins in the therapy and diagnosis of lung cancer | |
| EP1918300A3 (de) | Auf Peptiden basierende Immunisierungstherapie zur Behandlung von Atherosklerose | |
| DE69922822D1 (de) | Rekombinante haarbehandlungsmittel | |
| NZ279963A (en) | Human tissue inhibitor of metalloproteinase-4 (timp-4) and dna (rna) encoding polypeptide which may be derived from atcc 75946 | |
| CA2234263A1 (fr) | Composition pharmaceutique contre les tumeurs et infections a papillomavirus | |
| DK1025236T3 (da) | Human checkpoint kinase, HCDS1, præparater og fremgangsmåde | |
| WO1997022695A3 (fr) | Sequences nucleotidiques, proteines, medicaments et agents diagnostiques utiles dans le traitement du cancer | |
| EP1071443A4 (de) | Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen | |
| ATE218064T1 (de) | Immunogene tlp-zusammensetzung | |
| DE60118359D1 (de) | Humanische pellino-polypeptide | |
| AU1239997A (en) | Polypeptides corresponding to the amino acid sequences of proteins p57 or p9.5 of Borna disease virus, nucleic acid fragments coding therefore and their use for diagnostic and immunization purposes | |
| EA200100395A1 (ru) | Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием | |
| AU3711597A (en) | A novel galanin receptor | |
| PT782630E (pt) | Gene da doenca poliquistica do rim | |
| GB2357507A (en) | Peptide fragments of cholera toxin B or enterotoxin B as vaccine adjuvants | |
| ATE312923T1 (de) | Moraxella catarrhalis basb034 polypeptide und verwendungen davon | |
| DE60036676D1 (de) | G-protein-gekoppelter rezeptor-ähnliche proteine | |
| WO2000026362A3 (de) | Proteine der stomatinfamilie und ihre verwendung als zielproteine für die schmerztherapie | |
| WO2004089980A3 (en) | Therapeutic cancer vaccine | |
| SE9604439D0 (sv) | New receptor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |